Maximum quantity allowed is 999
Please select the quantity
CAS RN: 202590-98-5 | Product Number: O0482
OTX 015
Purity: >98.0%(HPLC)
Synonyms:
- 2-[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide
Documents:
Size | Unit Price | Saitama (Kawaguchi) | Hyogo (Amagasaki) | Stock in other WH |
---|---|---|---|---|
10MG |
¥25,300
|
3 | 14 | Contact Us |
50MG |
¥87,500
|
7 | 15 | Contact Us |
Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock in other WH: 2-3 Business Days
* Please contact us if you need further information.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* Please contact us if you need further information.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | O0482 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__5H__2__2ClN__5O__2S = 491.99 |
Physical State (20 deg.C) | Solid |
Storage Temperature | <0°C |
Condition to Avoid | Heat Sensitive |
CAS RN | 202590-98-5 |
Reaxys Registry Number | 13264398 |
MDL Number | MFCD26960949 |
Specifications
Appearance | White to Light yellow to Light orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Elemental analysis(Nitrogen) | 13.50 to 15.00 % |
Properties (reference)
Melting Point | 220 °C |
GHS
Related Laws:
Transport Information:
Application
Potent BET Bromodomain Inhibitor
References
- 1) Bromodomains: a new target class for drug development
- 2) The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
- 3) Abstract C244: Development of the BET bromodomain inhibitor OTX015.
Articles/Brochures
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number
Incorrect Lot Number is entered
The requested analytical chart is not available. Sorry for the inconvenience.